Quick Answer
Sunshine Biopharma Inc. reported Gross Profit of $10.67 million for fiscal year 2024.
Sunshine Biopharma Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $10.67M | +27.9% |
| 2023 | $8.34M | +391.5% |
| 2022 | $1.70M | +1434.0% |
| 2021 | $110.6K | +142.7% |
| 2020 | $45.6K | +352.4% |
| 2019 | $10.1K | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.07M | +7.2% | -10.2% |
| June 30, 2025 | $3.42M | +45.3% | +25.4% |
| March 31, 2025 | $2.73M | +16.0% | -4.7% |
| September 30, 2024 | $2.87M | +44.0% | +21.6% |
| June 30, 2024 | $2.36M | +20.7% | +0.1% |
| March 31, 2024 | $2.35M | +28.8% | +18.3% |
| September 30, 2023 | $1.99M | +2869.4% | +1.9% |
| June 30, 2023 | $1.95M | +2482.2% | +6.8% |
- Sunshine Biopharma Inc. showed an increase of +27.9% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from Sunshine Biopharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: